fluvoxamine for the treatment of child and adolescent depression: an open label trial
نویسندگان
چکیده
objective: major depressive disorder is a severe disorder that has a significant impact on the psychological and social functioning of children and adolescents. considering current limitations in the treatment of this disorder, the present study was performed to evaluate the efficacy of fluvoxamine in the treatment of children and adolescents with major depressive disorder. method: in an open trial, the efficacy of fluvoxamine (50-200 mg/d) on children and adolescents with major depressive disorder or dysthymic disorder was evaluated using the 'children's depression inventory', the 'hamilton anxiety rating scale', the 'children - global assessment scale', the 'clinical global impression scale', and the 'drug side effect questionnaire' at the beginning and 2, 4, and 8 weeks after the beginning of the treatment. the frequency of suicidal ideas was evaluated as well. results: treatment with fluvoxamine caused statistically significant improvement in all of the above scales. the frequency of suicidal ideas decreased from 88.9 percent to zero after 8 weeks. no significant side effects were observed. conclusion: fluvoxamine can be used as a safe and effective drug in the treatment of major depressive disorder and dysthymic disorder of children and adolescents.
منابع مشابه
Fluvoxamine for the Treatment of Child and Adolescent Depression: An Open Label Trial
Corresponding author: Ali Alavi, Child and Adolescent Psychiatrist, Department of Child and Adolescent Psychiatry, Roozbeh Hospital, South Kargar Ave., Tehran, Iran. email: [email protected] Tel: +98-917-3055282 Objective: Major depressive disorder is a severe disorder that has a significant impact on the psychological and social functioning of children and adolescents. Considering current...
متن کاملFluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.
OBJECTIVE Fluvoxamine, a monocyclic, specific serotonin uptake inhibitor with demonstrated efficacy in obsessive-compulsive disorder (OCD) and depression in adults, is marketed in more than 30 countries worldwide, including Israel. In the United States, where fluvoxamine is available only on an investigational basis, marketing appears imminent. This study evaluates the safety and efficacy of fl...
متن کاملEfficacy of prokinetic agents in diabetic gastroparesis comparing symptomatology and scintigraphy – An open-label trial
Background: It is pertinent to objectively assess the severity of diabetic gastroparesis and tailor treatment accordingly. The current study was planned to document gastroparesis by gastric emptying scintigraphy (GES) objectively and see the effect of medications and diet control on clinical and GES after four weeks. Methods: A prospective, open-label randomized trial was conducted in the Depa...
متن کاملRepetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
BACKGROUND RTMS has been developed as a novel tool for treating depression but the clinical significance of this treatment has been variable, especially in the older depressed subjects. METHODS Medication-resistant depressed patients 60 years or older were treated for two weeks (10 sessions) with high-frequency rTMS delivered to the left dorsolateral prefrontal cortex at 100% of motor thresho...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of psychiatryجلد ۳، شماره ۴، صفحات ۱۱-۱۵
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023